NEW HAMPTON, N.Y., Feb. 20, 2018 -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Tuesday, February 27, 2018 at 11:00 AM Eastern Time (ET) to review fourth quarter and full year 2017 results. Ted Harris, Chairman of the Board, CEO and President, Terry Coelho, CFO and Bill Backus, CAO, will host the call.
Fourth quarter results will be published prior to the market opening on Tuesday, February 27, 2018. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call.
We invite you to listen to the conference by calling toll-free 1-877-407-8289 (local dial-in 1-201-689-8341), five minutes prior to the scheduled start time of the conference call. The conference call will be available for replay two hours after the conclusion of the call through end of day Tuesday, February 27, 2018. To access the replay of the conference call, dial 1-877-660-6853 (local dial-in 1-201-612-7415), and use conference ID #13676648.
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications.
Contact: Mary Ann Brush, Executive Assistant to CEO
Telephone: 845-326-5600
E-mail: [email protected]


Airbus Joins Air India A320 Altitude Drop Probe
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Nvidia Secures $500 Billion AI Infrastructure Push With Wall Street Giants
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Natura Q2 Profit Plunges 92% as Financial Expenses Weigh on Earnings
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
DeepSeek to Raise AI API Prices as Demand for New Models Surges 



